Trials / Completed
CompletedNCT04264962
Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Beijing Ditan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Clinical research of Yang Yin Fu Zheng Jie Du therapy in recurrence of Hepatocellular Carcinoma less than 3 cm in diameter.The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy in 1 year recurrence for patients belong to Hepatocellular Carcinoma less than 3 cm in diameter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yang Yin Fu Zheng Jie Du therapy | Yang Yin Fu Zheng Jie Du is a Chinese herbal compound. |
| OTHER | Routine medical care | Routine medical care |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2020-02-11
- Last updated
- 2021-10-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04264962. Inclusion in this directory is not an endorsement.